{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:40:56Z","timestamp":1792726856300,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.farma.2026.09.004","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:29:23Z","timestamp":1792726163000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of Helicobacter pylori eradication with levofloxacin in immune thrombocytopenia: a prospective controlled study in Iraq"],"prefix":"10.1016","author":[{"given":"Murtadha Salah","family":"Shyaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal Khalid","family":"Abdulridha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseen Muhi","family":"AL Deen Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.farma.2026.09.004_bb0005","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.farma.2026.09.004_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MOH.0b013e3282ab98c7","article-title":"The epidemiology of immune thrombocytopenic purpura","volume":"14","author":"Fogarty","year":"2007","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"10.1016\/j.farma.2026.09.004_bb0015","first-page":"4003","article-title":"Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura","volume":"112","author":"Neunert","year":"2008","journal-title":"Blood J Am Soc Hematol"},{"issue":"12","key":"10.1016\/j.farma.2026.09.004_bb0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/medicina56120667","article-title":"Immune thrombocytopenia (ITP): current limitations in patient management","volume":"56","author":"Terrell","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.farma.2026.09.004_bb0025","doi-asserted-by":"crossref","DOI":"10.21037\/aob-21-23","article-title":"The treatment of immune thrombocytopenia (ITP)\u2014focus on thrombopoietin receptor agonists","volume":"6","author":"Kuter","year":"2021","journal-title":"Ann Blood"},{"issue":"4","key":"10.1016\/j.farma.2026.09.004_bb0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.amjmed.2004.09.014","article-title":"Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura","volume":"118","author":"Stasi","year":"2005","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.farma.2026.09.004_bb0035","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3748\/wjg.v20.i3.714","article-title":"Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms","volume":"20","author":"Kuwana","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"15","key":"10.1016\/j.farma.2026.09.004_bb0040","first-page":"11","article-title":"Response to Helicobacter pylori eradication triple therapy in peptic ulcer disease patients on curcumin supplement according to different ABO phenotypes","volume":"9","author":"Abbas","year":"2018","journal-title":"Karbala J Pharm Sci"},{"key":"10.1016\/j.farma.2026.09.004_bb0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/asheducation-2008.1.206","article-title":"Helicobacter pylori and chronic ITP","volume":"1","author":"Stasi","year":"2008","journal-title":"Hematol ASH Educ Program"},{"key":"10.1016\/j.farma.2026.09.004_bb0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jac\/dkm195","article-title":"Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"60","author":"Franchini","year":"2007","journal-title":"J Antimicrobial Chemother"},{"issue":"1","key":"10.1016\/j.farma.2026.09.004_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5045\/br.2021.2020189","article-title":"Effect of Helicobacter pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East","volume":"56","author":"Pezeshki","year":"2021","journal-title":"Blood Res"},{"key":"10.1016\/j.farma.2026.09.004_bb0060","series-title":"Essentials of haematology","article-title":"Bleeding disorders caused by abnormalities of platelets","author":"Kawthalkar","year":"2006"},{"key":"10.1016\/j.farma.2026.09.004_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1532\/IJH97.04161","article-title":"Helicobacter pylori infection and idiopathic thrombocytopenic purpura","volume":"81","author":"Fujimura","year":"2005","journal-title":"Int J Hematol"},{"issue":"9131","key":"10.1016\/j.farma.2026.09.004_bb0070","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini","year":"1998","journal-title":"The Lancet"},{"key":"10.1016\/j.farma.2026.09.004_bb0075","first-page":"3995","article-title":"Effect of Helicobacter pylori infection on the first-line treatment outcomes in patients with immune thrombocytopenic purpura","volume":"26","author":"Dogan","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.farma.2026.09.004_bb0080","series-title":"Technical manual","author":"Association for the Advancement of B, Biotherapies","year":"2020"},{"key":"10.1016\/j.farma.2026.09.004_bb0085","series-title":"WHO guidelines on drawing blood: best practices in phlebotomy","author":"World Health O","year":"2010"},{"issue":"2","key":"10.1016\/j.farma.2026.09.004_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bpg.2006.11.002","article-title":"Diagnosis of Helicobacter pylori: invasive and non-invasive tests","volume":"21","author":"Ricci","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.farma.2026.09.004_bb0095","first-page":"1730","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Off J Am College Gastroenterol|ACG"},{"key":"10.1016\/j.farma.2026.09.004_bb0100","doi-asserted-by":"crossref","unstructured":"Hattab M, Milhem F, Jallad H. Helicobacter pylori eradication for immune thrombocytopenia reduces non-response and raises platelet counts: meta-analysis of randomized trials; 2024. doi:10.21203\/rs.3.rs-7951511\/v1.","DOI":"10.21203\/rs.3.rs-7951511\/v1"},{"key":"10.1016\/j.farma.2026.09.004_bb0105","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1038\/s41598-020-66460-5","article-title":"Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.farma.2026.09.004_bb0110","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.htct.2024.03.008","article-title":"Relationship between response to first-line steroid treatment in adult immune thrombocytopenic purpura and the course of the disease","volume":"46","author":"Se\u00e7kin","year":"2024","journal-title":"Hematol Transfus Cell Therapy"},{"issue":"7","key":"10.1016\/j.farma.2026.09.004_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70236","article-title":"Characteristics of corticosteroid-resistant secondary immune thrombocytopenia associated with connective tissue diseases in China: a retrospective comparative study","volume":"13","author":"Chen","year":"2025","journal-title":"Immun Inflamm Dis"},{"issue":"2","key":"10.1016\/j.farma.2026.09.004_bb0115","doi-asserted-by":"crossref","first-page":"06","DOI":"10.37185\/LnS.1.1.341","article-title":"Comparative effectiveness of levofloxacin-based triple regimen and standard clarithromycin-based triple regimen in eradication of Helicobacter pylori","volume":"6","author":"Ahmed","year":"2025","journal-title":"Life Sci"},{"key":"10.1016\/j.farma.2026.09.004_bb0120","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-022-04782-2","article-title":"Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study","volume":"101","author":"Han","year":"2022","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.farma.2026.09.004_bb0135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ueg2.12569","article-title":"Role of compliance in Helicobacter pylori eradication treatment: results of the European registry on H. pylori management","volume":"12","author":"Huguet","year":"2024","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.farma.2026.09.004_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.31351\/vol22iss1pp97-103","article-title":"The relationship between ABO blood group distribution and the incidence of upper gastric and duodenal ulcer in Iraqi patients","volume":"22","author":"Abdulridha","year":"2013","journal-title":"Iraqi J Pharm Sci"},{"issue":"4","key":"10.1016\/j.farma.2026.09.004_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12989","article-title":"Reinforced medication adherence improves Helicobacter pylori eradication rate in developing countries: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Zeng","year":"2023","journal-title":"Helicobacter"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326002217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326002217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:29:30Z","timestamp":1792726170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634326002217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S1130634326002217"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2026.09.004","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of Helicobacter pylori eradication with levofloxacin in immune thrombocytopenia: a prospective controlled study in Iraq","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}